Search

Date 2021 Author/Creator Bahuaud, Mathilde

1. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Issue 4 (April 2021)

Authors:
Pollard, Andrew J; Launay, Odile; Lelievre, Jean-Daniel; Lacabaratz, Christine; Grande, Sophie; Goldstein, Neil; Robinson, Cynthia; Gaddah, Auguste; Bockstal, Viki; Wiedemann, Aurelie; Leyssen, Maarten; Luhn, Kerstin; Richert, Laura; Bétard, Christine; Gibani, Malick M; Clutterbuck, Elizabeth A; ...
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 4(2021)
Page Start:
493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search